1 Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation. 2021;144(6):471–84.
2 Halliday BP, Wassall R, Lota AS, Khalique Z, Gregson J, Newsome S, et al. Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2019;393(10166):61–73.
3 Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021;18(3):169–93.
4 Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360(15):1526–38.
5 Sundbom P, Suutari AM, Abdulhadi K, Broda W, Csegedi M. Salmonella enteritidis causing myocarditis in a previously healthy 22-year-old male. Oxf Med Case Reports. 2018;2018(12):omy106.
6 Papamichalis P, Argyraki K, Papamichalis M, Loukopoulos A, Dalekos GN, Rigopoulou EI. Salmonella enteritidis infection complicated by acute myocarditis: a case report and review of the literature. Cardiol Res Pract. 2011;2011:574230.
7 Burt CR, Proudfoot JC, Roberts M, Horowitz RH. Fatal myocarditis secondary to Salmonella septicemia in a young adult. J Emerg Med. 1990;8(3):295–7.
8 Oziol E, Bonal J, Chauveau E, Talard P, Carli P, Chagnon A. Acute myocarditis in non-typhoid Salmonella infection. Arch Mal Coeur Vaiss. 1995;88(1):99–101.
9 Neuwirth C, Francois C, Laurent N, Pechinot A. Myocarditis due to Salmonella virchow and sudden infant death. Lancet. 1999;354(9183):1004.
10 Wanby P, Olsen B. Myocarditis in a patient with salmonella and campylobacter enteritis. Scand J Infect Dis. 2001;33(11):860–2.
11 Franczuk P, Rewiuk K, Grodzicki T. Myocarditis related to Salmonella enteritidis infection. Cardiol J. 2007;14(6):589–91.
12 Childs L, Gupta S. Salmonella enteritidis induced myocarditis in a 16-year-old girl. BMJ Case Rep. 2012;2012:bcr2012007628.
13 Sanders V, Misanik LF. Salmonella myocarditis. Report of a case with ventricular rupture. Am Heart J. 1964;68:682–5.
14 Al Shamkhani W, Ajaz Y, Saeed Jafar N, Roy Narayanan S. Myocarditis and rhabdomyolysis in a healthy young man caused by salmonella gastroenteritis. Case Rep Infect Dis. 2015;2015:954905.
15 Markaki L, Spernovasilis N, Lempidakis D, Kokorakis E, Gialamas I, Petousis S, et al. Non-typhoidal Salmonella myocarditis in an immunocompetent young adult with diarrhea. Pan Afr Med J. 2019;34:117.
16 Chehab O, McGuire E, Wani RLS, Weerackody R. Acute myopericarditis caused by Salmonella enterica serovar Enteritidis: a case report. Eur Heart J Case Rep. 2020;4(4):1–5.
17 Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32(2):263–9.
18 Villablanca P, Mohananey D, Meier G, Yap JE, Chouksey S, Abegunde AT. Salmonella Berta myocarditis: Case report and systematic review of non-typhoid Salmonella myocarditis. World J Cardiol. 2015;7(12):931–7.
19 Ungprasert P, Srivali N, Thongprayoon C. Nonsteroidal anti-inflammatory drugs and risk of incident heart failure: A systematic review and meta-analysis of observational studies. Clin Cardiol. 2016;39(2):111–8.
20 Costanzo-Nordin MR, Reap EA, O’Connell JB, Robinson JA, Scanlon PJ. A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. J Am Coll Cardiol. 1985;6(5):1078–82.
21 Shane AL, Mody RK, Crump JA, Tarr PI, Steiner TS, Kotloff K, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. Clin Infect Dis. 2017;65(12):e45–80.
22 Jin D, Kao CY, Darby J, Palmer S. Salmonella typhimurium myopericarditis: A case report and review of literature. World J Cardiol. 2020;12(1):67–75.
23 Kim HW, Jenista ER, Wendell DC, Azevedo CF, Campbell MJ, Darty SN, et al. Patients with acute myocarditis following mRNA COVID-19 vaccination. JAMA Cardiol. 2021;6(10):1196–201.
24 Montgomery J, Ryan M, Engler R, Hoffman D, McClenathan B, Collins L, et al. Myocarditis following immunization with mRNA COVID-19 vaccines in members of the US military. JAMA Cardiol. 2021;6(10):1202–6.
25 Haaf P, Kuster GM, Mueller C, Berger CT, Monney P, Burger P, et al. The very low risk of myocarditis and pericarditis after mRNA COVID-19 vaccination should not discourage vaccination. Swiss Med Wkly. 2021;151:w30087.
26 Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, et al. Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting. N Engl J Med. 2021;385(12):1078–90.
27 Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19(2):75–7.
28 Woo W, Kim AY, Yon DK, Lee SW, Hwang J, Jacob L, et al. Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine. J Med Virol. 2022;94(4):1566–80.
29 Witberg G, Barda N, Hoss S, Richter I, Wiessman M, Aviv Y, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021;385(23):2132–9.
30 Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: Update from the Advisory Committee on Immunization Practices – United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(27):977–82.